skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
PIM Kinase Inhibitor SGI-1776 (Code C82404)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: PIM Kinase Inhibitor SGI-1776

Definition: A small-molecule pan-PIM protein kinase inhibitor with potential antineoplastic activity. PIM kinase inhibitor SGI-1776 binds to and inhibits the activities of PIM-1, -2 and -3 serine/threonine kinases, which may result in the interruption of the G1/S phase cell cycle transition, the expression of pro-apoptotic Bcl2 proteins and tumor cell apoptosis. PIM kinases play key roles in cell cycle progression and apoptosis inhibition and may be overexpressed in various malignancies.

Display Name: PIM Kinase Inhibitor SGI-1776

Label: PIM Kinase Inhibitor SGI-1776

NCI Thesaurus Code: C82404 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C2742218  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
PIM Kinase Inhibitor SGI-1776

External Source Codes: 
PDQ Closed Trial Search ID 638088
PDQ Open Trial Search ID 638088 (check for NCI PDQ open clinical trial info)
UMLS CUI C2742218

Other Properties:
     Name Value (qualifiers indented underneath)
code C82404
Contributing_Source CTRP
Legacy_Concept_Name Pim_Kinase_Inhibitor_SGI-1776
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom